Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer

Trial ID or NCT#

NCT02530606

Status

not recruiting iconNOT RECRUITING

Purpose

This pilot clinical trial studies how well photoacoustic imaging works in detecting ovarian or fallopian tube cancer. Photoacoustic imaging is an imaging method that uses lasers to light up tissue, and then converts the light information into ultrasound images. Photoacoustic imaging can provide images of the structure of tissues, as well as their function and the levels of molecules, such as the flow of blood in blood vessels and the level of oxygen in the blood. Photoacoustic imaging may help doctors determine whether a mass is benign (non-cancerous) or cancerous based on the molecular differences between cancer and normal tissue. It may be more accurate and less expensive than other imaging methods, and does not expose patients to radiation.

Official Title

Transvaginal Ultrasound and Photoacoustic Imaging of the Ovaries and the Fallopian Tubes: A Clinical Feasibility Study

Eligibility Criteria

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Patients must be undergoing ovarian resection* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
  1. * Patients who have had primary surgical excision* Pregnant or lactating women

Investigator(s)

Sanjiv Sam Gambhir, MD, PhD
Jonathan S. Berek, MD, MMSc
Jonathan S. Berek, MD, MMSc
Gynecologic oncologist
Laurie Kraus Lacob Professor

Contact us to find out if this trial is right for you.

Contact

Sri-Rajasekhar Kothapalli